Disclaimer: This site is for informational purposes only. Not medical advice. Always consult a qualified healthcare professional before using any peptide or supplement.
Tirzepatide
MetabolicAlso known as: Mounjaro peptide, dual GIP/GLP-1 agonist
Overview
Tirzepatide is a novel dual GIP and GLP-1 receptor agonist. Clinical trials have shown superior weight loss results compared to semaglutide, making it one of the most effective metabolic peptides available.
Mechanism of Action
Tirzepatide activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors simultaneously. This dual mechanism provides additive metabolic benefits including enhanced insulin secretion, appetite suppression, and improved energy expenditure.
Common Research Uses
- Weight loss
- Metabolic optimization
- Blood sugar control
- Body recomposition
Vendors That Carry Tirzepatide
Learn More in the Peptide Playbook
Get comprehensive protocols, dosing information, and vendor selection guidance.
Get the Full Guide →